Target Audience:

This activity has been designed to meet the educational needs of APP's involved in the care of patients with rheumatic disease.

Program Overview

Each summit will feature a program focusing on hot topics in RA, PsA, AS, axSpa, JIA, biosimilars, bone disease, PMR, lupus nephritis, SLE, and vasculitis. The presentations are designed to reach community NPs, PAs, and PharmDs who may be unable to attend the annual RhAPP National Conference.

Educational Objectives:

After completing this activity, the participant should be better able to:

• Describe the latest clinical guidelines and treatment recommendations for the management of rheumatic disease
• Individualized treatment and dosing for patients with rheumatic disease by assessing the latest evidence-based benefits of the available treatments
• Assess the risk factors associated with each treatment recommendation and carefully monitor patients for adverse events
• Evaluate new treatment options for rheumatic disease and therapeutics development
• Assess the risk-benefit for patients receiving new therapeutics for rheumatic disease

Industry-employed healthcare providers are not permitted to register unless sponsoring the meeting. Registrants must be active advanced practice providers in a community or academic setting.

If interested in sponsoring an event, please contact
Anne Michaels at amichaels@taggrp.com